{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:22:53Z","timestamp":1790097773047,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jiac.2023.03.009","type":"journal-article","created":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T22:03:16Z","timestamp":1678744996000},"page":"673-677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1705-645X","authenticated-orcid":false,"given":"Murat","family":"Kucuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Heybeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Celal","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-7576","authenticated-orcid":false,"given":"Bi\u015far","family":"Ergun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3542-3906","authenticated-orcid":false,"given":"Mehmet Nuri","family":"Yakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3225-7666","authenticated-orcid":false,"given":"Ali Necati","family":"Gokmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilgin","family":"Comert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beg\u00fcm","family":"Ergan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2023.03.009_bib1","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s10096-019-03546-7","article-title":"Rat models of colistin nephrotoxicity: previous experimental researches and future perspectives","volume":"38","author":"Heybeli","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.009_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijantimicag.2009.10.005","article-title":"Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients","volume":"35","author":"Falagas","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2023.03.009_bib3","article-title":"Colistin-induced acute kidney injury and the effect on survival in patients with multidrug-resistant gram-negative infections: significance of drug doses adjusted to ideal body weight","volume":"2021","author":"Arrayasillapatorn","year":"2021","journal-title":"Internet J Nephrol"},{"key":"10.1016\/j.jiac.2023.03.009_bib4","article-title":"Characteristics, influencing factors, predictive scoring system, and outcomes of the patients with nephrotoxicity associated with administration of intravenous colistin","volume":"11","author":"Sangthawan","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2023.03.009_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijid.2006.09.011","article-title":"Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand","volume":"11","author":"Koomanachai","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.009_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030653","article-title":"Molecular mechanisms of colistin-induced nephrotoxicity","volume":"24","author":"Gai","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jiac.2023.03.009_bib7","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/cc10283","article-title":"Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice","volume":"15","author":"Gu","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2023.03.009_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08860220802546487","article-title":"Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study","volume":"31","author":"Kocoglu","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.jiac.2023.03.009_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PCC.0000000000000611","article-title":"Dexmedetomidine is associated with lower incidence of acute kidney injury after congenital heart surgery","volume":"17","author":"Kwiatkowski","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jiac.2023.03.009_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1590\/S0102-865020160010000002","article-title":"Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia\/reperfusion injury in rats","volume":"31","author":"Liu","year":"2016","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.jiac.2023.03.009_bib11","first-page":"1843","article-title":"Dexmedetomidine protects against ischemia\/reperfusion injury in rat kidney","volume":"18","author":"Si","year":"2014","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jiac.2023.03.009_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1272\/jnms.80.131","article-title":"Continuous infusion of dexmedetomidine improves renal ischemia-reperfusion injury in rat kidney","volume":"80","author":"Sugita","year":"2013","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.jiac.2023.03.009_bib13","doi-asserted-by":"crossref","first-page":"F741","DOI":"10.1152\/ajprenal.90244.2008","article-title":"alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice","volume":"295","author":"FTt","year":"2008","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.jiac.2023.03.009_bib14","first-page":"579","article-title":"Investigation of the nephroprotective effect of dexmedetomidine on colistin-induced nephrotoxicity in rats","volume":"123","author":"Canakci","year":"2022","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jiac.2023.03.009_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bjan.2018.01.017","article-title":"[Does dexmedetomidine prevent colistin nephrotoxicity?]","volume":"68","author":"Talih","year":"2018","journal-title":"Braz J Anesthesiol"},{"key":"10.1016\/j.jiac.2023.03.009_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00011-017-1023-9","article-title":"Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation","volume":"66","author":"Liang","year":"2017","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jiac.2023.03.009_bib17","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/cid\/civ964","article-title":"Updated US and European dose recommendations for intravenous colistin: how do they perform?","volume":"62","author":"Nation","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.009_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/21505594.2016.1152440","article-title":"Bloodstream Infections: the peak of the iceberg","volume":"7","author":"Viscoli","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.jiac.2023.03.009_bib20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jiac.2023.03.009_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jiac.2023.03.009_bib23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.jiac.2023.03.009_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jac\/dkr483","article-title":"Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics","volume":"67","author":"Yousef","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/0886022X.2018.1489286","article-title":"N-acetylcysteine suppresses colistimethate sodium-induced nephrotoxicity via activation of SOD2, eNOS, and MMP3 protein expressions","volume":"40","author":"Ceylan","year":"2018","journal-title":"Ren Fail"},{"key":"10.1016\/j.jiac.2023.03.009_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00134-010-2038-7","article-title":"Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?","volume":"37","author":"Ozyilmaz","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2023.03.009_bib27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1128\/AAC.03925-14","article-title":"Lycopene attenuates colistin-induced nephrotoxicity in mice via activation of the Nrf2\/HO-1 pathway","volume":"59","author":"Dai","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib28","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1080\/0886022X.2016.1229995","article-title":"Luteolin ameliorates colistin-induced nephrotoxicity in the rat models","volume":"38","author":"Arslan","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/j.jiac.2023.03.009_bib29","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1093\/jac\/dkx185","article-title":"Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response","volume":"72","author":"Dai","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib30","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.etap.2014.03.004","article-title":"Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model","volume":"37","author":"Ghlissi","year":"2014","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1016\/j.jiac.2023.03.009_bib31","first-page":"463","article-title":"Alpha-tocopherol ameliorates nephrotoxicity associated with the use of colistin in rabbits","volume":"31","author":"Bader","year":"2018","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.jiac.2023.03.009_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biopha.2018.10.093","article-title":"The nephroprotective properties of taurine in colistin-treated mice is mediated through the regulation of mitochondrial function and mitigation of oxidative stress","volume":"109","author":"Heidari","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jiac.2023.03.009_bib33","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/nau.23249","article-title":"Possible protective role of silybin against polymyxin E-induced toxic effect in rat kidneys: a biochemical approach","volume":"36","author":"Hassan","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jiac.2023.03.009_bib34","article-title":"P-glycoprotein induction ameliorates colistin induced nephrotoxicity in cultured human proximal tubular cells","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2023.03.009_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/0960327120966043","article-title":"Alpha-lipoic acid alleviates colistin nephrotoxicity in rats","volume":"40","author":"Oktan","year":"2021","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.jiac.2023.03.009_bib36","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00328-11","article-title":"Melatonin attenuates colistin-induced nephrotoxicity in rats","volume":"55","author":"Yousef","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib37","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.00280-15","article-title":"Preliminary clinical study of the effect of ascorbic acid on colistin-associated nephrotoxicity","volume":"59","author":"Sirijatuphat","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib38","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3855\/jidc.9459","article-title":"Colistin-induced nephrotoxicity and the role of N-acetylcysteine: a retrospective cohort study","volume":"11","author":"Bozkurt","year":"2017","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jiac.2023.03.009_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1120009X.2020.1770027","article-title":"Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?","volume":"33","author":"Heybeli","year":"2021","journal-title":"J Chemother"},{"key":"10.1016\/j.jiac.2023.03.009_bib40","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40520-017-0827-3","article-title":"Colistin nephrotoxicity in the ICU: is it different in the geriatric patients?","volume":"30","author":"Aydogan","year":"2018","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jiac.2023.03.009_bib41","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/ijn.IJN_130_20","article-title":"Colistin nephrotoxicity-age and baseline kidney functions hold the key","volume":"31","author":"Prasannan","year":"2021","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.jiac.2023.03.009_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12941-015-0062-8","article-title":"High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia","volume":"14","author":"Omrani","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jiac.2023.03.009_bib43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/cid\/cir611","article-title":"Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system","volume":"53","author":"Pogue","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2023.03.009_bib44","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/phar.1271","article-title":"Emergent renal dysfunction with colistin pharmacotherapy","volume":"33","author":"Collins","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2023.03.009_bib45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/CCM.0000000000000931","article-title":"Association between colistin dose and development of nephrotoxicity","volume":"43","author":"Lee","year":"2015","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jiac.2023.03.009_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ACO.0b013e328305e3ef","article-title":"Dexmedetomidine: a review of clinical applications","volume":"21","author":"Carollo","year":"2008","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.jiac.2023.03.009_bib47","first-page":"13","article-title":"Dexmedetomidine: a novel sedative-analgesic agent","volume":"14","author":"Gertler","year":"2001","journal-title":"SAVE Proc"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23000697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X23000697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:06:33Z","timestamp":1761159993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X23000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1341321X23000697"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2023.03.009","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine may reduce the risk of acute kidney injury development in critically ill patients during colistin therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2023.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}